| Application no. and date | 98961430.0 (espacenet) (Federated) (European Patent Register), 19981221 | | Patent/reg. no. and date | DK/EP 1040830, 20050608 | | Publication date | 20001004 | | Priority no. and date | JP 36931397, 19971226 | | EP pub. no. and date |
EP 1040830 20001004 | | Effective date | | | Applicant/owner | Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome
Chuo-ku, Osaka-shi, Osaka-fu
Osaka 541-8524, JP | | Applicant ref. no. | P38554dk01 | | Inventor | MASUDA, Yoshinobu, 49-1, Kisaichi 6-chome
Katano-shi,
Osaka 576-0033, JP,
OCHI, Yoshiaki, 7-17, Fujigaoka 4-chome
Sanda-shi,
Hyogo 669-1547, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/42 (2006.01) , A61K 31/423 (2006.01) , A61P 25/16 (2006.01) , A61P 25/28 (2006.01) , C07D 261/20 (2006.01) | | Title | Lægemiddel til neurodegenerative sygdomme | | Int. application no. | JP1998005757 | | Int. publication no. | WO1999033465 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
